The Life Sciences Rendez-vous : Bioprocess, Suspension - PART 2/3.
Attend our new compact webinars series (30min) in your local language.
See Part 1, Part 3 and other languages on our webinar page.
Careful vessel selection at all scales enhances space efficacy, reducing cost and labor hours. Suspension processes play a key role in the biopharmaceuticals market, where suspension cell systems are used to produce antibodies and recombinant proteins. This webinar will provide an overview of Corning's suspension culture portfolio, relevant to both R&D and production scenarios, supported by experimental data from our global applications team.
Dr. Sonia Meconi
Sonia’s scientific background covers different fields such as biochemistry, cell biology, and immunology where she obtained a Ph.D., specifically in human infectious diseases working on a daily basis in a biologic level 3 lab. After a post-doctoral fellow and lecturer experience, she took over the head of the R&D and production teams in a small biotech which developed human serological diagnosis assays for infectious and autoimmune diseases. She oversaw pathogens (bacteria and virus) expansion supervision for protein microarray tests. Then, she joined an international company as an Application Specialist for cell culture and purification, creating new cell culture media dedicated to vaccines and cell therapy markets. Now, she joined Corning as Bioprocess Specialist working for different suppliers for the biopharmaceutical industry.